Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Davis: Determinants of Diabetes-Attributable Non–Blood Glucose–Lowering Medication Costs.... (0.09 sec) 

Determinants of Diabetes-Attributable Non–Blood Glucose–Lowering Medication …

- diabetesjournals.org
WA Davis, MW Knuiman, D Hendrie, TME Davis - Diabetes care, 2005 - Am Diabetes Assoc
RESULTS— Non-BGL medications accounted for 75% of all prescription medication costs over
the study period, and one-third were attributable to diabetes. The median annual cost (in A$)
of non-BGL medications per patient increased from A$220 to A$429 over 4 years (P < ...
Cited by 9 - Related articles - All 5 versions

[CITATION] Glycaemic levels triggering therapeutic intensification in type 2 diabetes in the …


TME Davis, WA Davis, DG Bruce - Med J Aust, 2006
Cited by 4 - Related articles

Vascular depression in older people with diabetes


DG Bruce, G Casey, WA Davis, SE Starkstein, RC … - Diabetologia, 2006 - Springer
Page 1. ARTICLE Vascular depression in older people with diabetes DG Bruce &
G. Casey & WA Davis & SE Starkstein & RC Clarnette & JK Foster & FJ Ives & OP
Almeida & TME Davis Received: 23 March 2006 /Accepted: 25 ...
Cited by 3 - Related articles - BL Direct - All 6 versions

Silent myocardial infarction and its prognosis in a community-based cohort of Type …


TME Davis, P Fortun, J Mulder, WA Davis, DG Bruce - Diabetologia, 2004 - Springer
Aims/hypothesis. Our study investigated the prognosis of Type 2 diabetic patients with silent
myocardial in- farction in a community-based cohort. Methods. We analysed data from 1269
patients with Type 2 diabetes mellitus from a community-based ob- servational study of ...
Cited by 17 - Related articles - BL Direct - All 4 versions

[CITATION] Glycemic control in older diabetic patients in the Fremantle Diabetes Study


DG Bruce, WA Davis, TME Davis - J Am Geriatr Soc, 2000
Cited by 6 - Related articles

Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the …

- jhsph.edu [PDF] 
TME Davis, BB Yeap, WA Davis, DG Bruce - Diabetologia, 2008 - Springer
Abstract Aims/hypothesis The aim of this study was to assess the relationships between
lipid-lowering therapy and the preva- lence and incidence of peripheral sensory neuropathy
in type 2 diabetes mellitus. Methods We analysed data from an observational cohort ...
Cited by 9 - Related articles - BL Direct - All 5 versions

Prevalence and prognostic implications of the metabolic syndrome in community- …


TME Davis, DG Bruce, WA Davis - Diabetes Research and Clinical Practice, 2007 - Elsevier
To determine whether the metabolic syndrome (MS) predicts fatal outcome in type 1
diabetes, we assessed prospective data from 127 patients from the observational
community-based Fremantle Diabetes Study. Causes of death were classified as cardiac ...
Cited by 10 - Related articles - All 5 versions

Влияние компенсации углеводного обмена и терапии аторвастатином на …


ИВ Глинкина, АВ Зилов, ГА Мельниченко, АП … - Сахарный диабет, 2007 - elibrary.ru
Влияние компенсации углеводного обмена и терапии аторвастатином на липидный
обмен и уровнь С-реактивного белка у пациентов с сахарным диабетом 2 типа.
ИВ Глинкина, АВ Зилов, ГА Мельниченко, АП Ройтман ...
Related articles

The obesity-driven rising costs of type 2 diabetes in Australia: projections from the …


WA Davis, MW Knuiman, D Hendrie, TME … - Internal medicine …, 2006 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 11 - Related articles - All 5 versions

Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi- …


TME Davis, P Zimmet, WA Davis, DG Bruce, S … - Diabetic …, 2000 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 73 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google